European Foundation for the Study of Diabetes and
Boehringer Ingelheim European Diabetes Clinical Research Programme: Mechanisms relating renal dysfunction to cardiovascular disease in type 2 diabetes
Request for Applications
Deadline for submission of applications: 1 April 2015
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.
Boehringer Ingelheim is a global group of companies who seek to improve the health and wellbeing of people and animals through being a part of an independent, innovative, research and development driven company.
Programme and Research Focus
EFSD and Boehringer Ingelheim have established the EFSD/Boehringer Ingelheim European Clinical Diabetes Research Programme to encourage new projects aimed at advancing current knowledge in this domain.
To achieve the goals and objectives of this Programme, EFSD and Boehringer Ingelheim invite applications by issuing this "Request for Applications" (RFA), which indicates joint funding as well as areas of research emphasis.
The EFSD/Boehringer Ingelheim European Clinical Diabetes Research Programmes are intended to stimulate and accelerate European research in diabetes in the specific area of mechanisms relating renal dysfunction to cardiovascular disease in type 2 diabetes. In particular, proposals dealing with the following are especially, but not exclusively, welcome: investigating novel biomarkers in the clinical setting: the translation of experimental hypotheses into the clinical setting and with clinical results.
Mechanism of Support and Review
Research will be supported through the award of grants, each of up to to Euro 400,000 in total for projects lasting up to 3 years. According to the duration and timetable of the projects, funds will be made available annually. EFSD may, at the suggestion of the Review Committee, may at its discretion recommend an award in a different amount from that requested, but which is considered more appropriate for the proposed studies.
Applicants who have a funding requirement larger than that specified above are also invited to apply to this Programme; in this case, the relevant financial requirements should be indicated and justified in the budget section of the application form.
Studies forming part of a larger project will be considered for funding but this will need to be well justified in the application (see Review Considerations).
Applications for an EFSD/Boehringer Ingelheim grant are invited from single non-profit institutions or groups of such institutions from Europe and associated countries. The principal investigator and any co-investigators must be employed full-time at a non-profit institution and the study must be performed at their place of work.
Applications will be subject to scientific review by a specialised and independent ad hoc committee. It is anticipated that applications will be received, reviewed and approved for funding by June 2015.
Prior to any final decision on funding, and in order to offer applicants the opportunity to benefit from the review process, EFSD reserves the right to request revision of applications in accordance with the recommendations of the Review Committee.
Research Grant Applications
Applications for research grants may be subjected to pre-review (or triage) procedures. In this event, any application rejected at pre-review will not be subject to a complete scientific review.
The deadline for receipt of research grant applications for funding this year is 1 April 2015.
All budgets are to be prepared in Euro. For countries in which the Euro is not the common currency, the exchange rate (between the Euro and the local currency in the country where the work is to be performed) used for calculating the Euro budget must be mentioned under "Budget Justification".
All applications must be prepared on the official application form and completed in strict accordance with the detailed instructions to be found on these forms. Applications which do not comply with the instructions given in the application form will not be considered for review.
Please send your application as one complete PDF e-mail attachment to the following address before 12:00 midday (CET) on the deadline date:
Completed applications will be evaluated in accordance with the criteria stated below for scientific/technical merit by an appropriate and independent scientific committee.
Review criteria are as follows:
Significance: Does the study address an important problem in keeping with the goals and focus areas of this Programme? If the aims of the application are achieved, how will scientific knowledge be advanced? What will be the effect of the proposed studies on the concepts or methods that drive this field?
Approach: Are the conceptual framework, design, methods and analyses adequately developed, well integrated, and appropriate to the aims of the project? Are they supported by preliminary data? Does the applicant acknowledge potential problem areas and consider alternative tactics?
Innovation: Does the project employ novel concepts, approaches or methods? Are the aims original and innovative? Does the project challenge existing paradigms or develop new methodologies or technologies?
Investigator: Is the investigator appropriately trained and well suited to carry out this work? Is the work proposed appropriate to the experience level of the principal investigator and other researchers, if any?
Environment: Does the scientific environment in which the work will be done contribute to the probability of success? Do the proposed studies take advantage of unique features of the scientific environment or employ useful collaborative arrangements? Is there evidence of institutional support?
Budget: Is the requested budget appropriate for the proposed study? Is the requested duration suitable for completion of the project?
Contribution towards a larger research project: Is the work described in the application intended as part of a larger project? If so, is there any overlap? Is there a clear explanation how the new work will contribute towards the overall success of that larger project?
Reporting Requirements and Approval of Funding
All investigators funded by this Programme are required to submit a scientific report at the end of the project period. For those projects where funding is distributed over a period of more than one year, interim progress reports will also be required. Such reports will be subject to assessment prior to the release of any further funds.
Investigators must provide EFSD with copies of papers accepted for publication, and must acknowledge the support of the Programme in all written material by use of the phrase: "supported by an EFSD/Boehringer Ingelheim research grant".
Applications for a grant renewal will be accepted on a competitive basis, with the same review process as described in this Announcement. Such applications will thus be considered in the same fashion as all other new applications received for review and without any special priority.
Announcement: December 2014
Application Deadline: 1 April 2015
Anticipated Award Date: June 2015
Enquiries should be directed to:
European Foundation for the Study of Diabetes
Rheindorfer Weg 3
40591 Düsseldorf, Germany
Tel: + 49-211-75 84 69-0